Waters Parkerson & CO. LLC raised its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 9.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 358,710 shares of the company's stock after acquiring an additional 32,380 shares during the quarter. Waters Parkerson & CO. LLC owned approximately 0.14% of Ryan Specialty worth $23,015,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in RYAN. Raymond James Financial Inc. purchased a new stake in Ryan Specialty during the fourth quarter valued at about $94,484,000. Norges Bank purchased a new position in Ryan Specialty in the fourth quarter valued at about $78,358,000. Millennium Management LLC boosted its holdings in Ryan Specialty by 1,111.4% in the fourth quarter. Millennium Management LLC now owns 1,174,086 shares of the company's stock valued at $75,329,000 after purchasing an additional 1,077,169 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in Ryan Specialty by 115.2% during the 4th quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock worth $117,619,000 after buying an additional 981,505 shares during the last quarter. Finally, CIBC Private Wealth Group LLC lifted its holdings in Ryan Specialty by 6,911.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock worth $48,036,000 after buying an additional 774,718 shares during the last quarter. 84.82% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts have commented on RYAN shares. Keefe, Bruyette & Woods reduced their target price on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Barclays dropped their price target on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. UBS Group increased their price target on Ryan Specialty from $82.00 to $84.00 and gave the stock a "buy" rating in a research report on Wednesday, February 26th. Royal Bank of Canada dropped their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. Finally, Morgan Stanley increased their price target on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research report on Monday, May 19th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $75.58.
Check Out Our Latest Stock Analysis on RYAN
Ryan Specialty Price Performance
Shares of RYAN stock traded down $0.03 during mid-day trading on Friday, hitting $68.69. 548,694 shares of the stock traded hands, compared to its average volume of 982,781. Ryan Specialty Holdings, Inc. has a twelve month low of $52.34 and a twelve month high of $77.16. The firm has a market cap of $18.03 billion, a price-to-earnings ratio of 99.56, a price-to-earnings-growth ratio of 1.19 and a beta of 0.68. The company's 50-day simple moving average is $70.10 and its 200-day simple moving average is $68.79. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01.
Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.39. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company had revenue of $690.17 million for the quarter, compared to analysts' expectations of $680.80 million. During the same period last year, the firm earned $0.35 EPS. The firm's revenue for the quarter was up 25.0% on a year-over-year basis. As a group, equities research analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.
Ryan Specialty Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be paid a dividend of $0.12 per share. This represents a $0.48 annualized dividend and a dividend yield of 0.70%. The ex-dividend date is Tuesday, May 13th. Ryan Specialty's dividend payout ratio is presently 141.18%.
Insider Transactions at Ryan Specialty
In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 11.10% of the company's stock.
Ryan Specialty Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
See Also

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.